NICE IDs

11/10/2021

ID1557: Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies

11/10/2021

ID2727: Abemaciclib with fulvestrant for treating hormone receptor-positive, HER2-negative advanced breast cancer after endocrine therapy

11/10/2021

ID1087: Fostamatinib for treating persistent or chronic immune thrombocytopenia

11/10/2021

ID1393: Ponesimod for treating relapsing multiple sclerosis

11/10/2021

ID1573: Midostaurin for treating advanced systemic mastocytosis

11/10/2021

ID3826: Empagliflozin for treating chronic heart failure with reduced ejection fraction

11/10/2021

ID3741: Pembrolizumab with platinum-based chemotherapy for untreated advanced oesophageal cancer

11/10/2021

ID3866: Dapagliflozin for treating chronic kidney disease

11/10/2021

ID2692: Bimekizumab for treating moderate to severe chronic plaque psoriasis

11/10/2021

ID1620: Isatuximab with carfilzomib and dexamethasone for treating relapsed or refractory multiple myeloma

11/10/2021

ID1585: Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (CDF Review TA490)

11/10/2021

ID3942: Sacituzumab govitecan for treating metastatic or unresectable triple-negative breast cancer after 2 or more therapies

11/10/2021

ID3777: Atezolizumab for untreated PD-L1-positive locally advanced or metastatic urothelial cancer when cisplatin is unsuitable (CDF Review of TA492)

11/10/2021

ID1630: Liraglutide for managing obesity in people aged 12 to 17

11/10/2021

ID1590: Selumetinib for treating symptomatic and inoperable plexiform neurofibromas associated with type 1 neurofibromatosis in children aged 3 years and over

11/10/2021

ID1483: Roxadustat for treating anaemia in people with chronic kidney disease

11/10/2021

ID3839: Cemiplimab for untreated PD-L1-postive advanced or metastatic non-small-cell lung cancer

11/10/2021

ID1570: Odevixibat for treating progressive familial intrahepatic cholestasis

11/10/2021

ID1065: Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea

11/10/2021

ID3842: Relugolix with oestradiol and norethisterone acetate for treating uterine fibroids